NeuroPace (NPCE) Change in Acquisitions & Divestments (2020 - 2024)
NeuroPace's (NPCE) quarterly Change in Acquisitions & Divestments came in at $2.0 million in Q4 2024, down 42.86% year-on-year from $3.5 million in Q1 2024, and up 33.33% quarter-over-quarter from $1.5 million in Q3 2024.
NeuroPace (NPCE) Change in Acquisitions & Divestments (2020 - 2024) Analysis & Trends
NeuroPace's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $2.0 million for Q4 2024.
- On a quarterly basis, Change in Acquisitions & Divestments fell 42.86% year-over-year to $2.0 million in Q4 2024; TTM through Sep 2025 was $2.0 million, a 81.48% decrease from a year earlier, with the FY2024 full-year figure at $9.3 million, down 59.91% from the prior year.
- Change in Acquisitions & Divestments climbed to $2.0 million in Q4 2024 per NPCE's latest filing, from $1.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $10.2 million in Q1 2023 and bottomed at $1.5 million in Q3 2024.
- The 4-year median for Change in Acquisitions & Divestments is $4.8 million (2023), against an average of $5.3 million.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 36.9% in 2023 and plunged 75.49% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $6.3 million in 2020, then surged by 42.86% to $9.0 million in 2022, then plunged by 61.11% to $3.5 million in 2023, then tumbled by 42.86% to $2.0 million in 2024.
- Per Business Quant, the three latest NPCE Change in Acquisitions & Divestments figures stand at $2.0 million (Q4 2024), $1.5 million (Q3 2024), and $3.3 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 10.20 Mn |
| Mar 31, 2023 | 10.20 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Sep 30, 2022 | 7.00 Mn |